Since m orphine possesses th e phenanthrene ring structure, experim ents have been perform ed to investigate th e possibility of producing a simple analogue w ith a relationship sim ilar to th a t betw een oestrone and stilboestrol.
Whilst carefully planned researches to demonstrate the relationship between molecular structure and pharmacological action have usually resulted in the accumulation of a disappointing series of anomalies, empirical ventures in this field have frequently yielded interesting and sometimes useful results. This has been particularly demonstrated in the case of the steroid hormones. It is possible to have three distinct types of analogues capable of performing the same function.
(1) Molecules may have the same basic ring structure, but differ from the naturally occurring hormone only in the distribution of double bonds, polar groups, etc. A good example of this is the oestrogenic hormone oestradiol, where there is a whole series of substances, such as oestriol, oestrone, equilene, equilenine, having similar activity. Again, there are well over 150 substances with the same basic skeleton as testosterone with qualitatively the same androgenic activity.
(2) The hormone analogue may bear a loose chemical relationship to the original structure and may possess even greater activity than the actual hormone itself, as, for example, the synthetic oestrogens diethylstilboestrol, hexoestrol, and dienoestrol.
(3) A substance may be found which possesses the same action as a hormone and which bears no resemblance whatsoever in chemical constitution to the original. An example of this is the relationship between the hetero-auxins and auxin itself.
The relationship between stilboestrol and oestradiol is shown by formulae (I) and (II). Stilboestrol is even more active than the original hormone, and this suggested the application of the same type of reasoning to other biologically active substances containing the phenanthrene ring system. Morphine is such a substance, and this paper reports an attempt to obtain a synthetic morphine analogue. As a starting point it was decided to investigate the pharmacological activity of 120 diphenylethylamine. The structural relationship of this substance to morphine is shown in formulae (III) and (IV). E. C. Dodds, W. Lawson and P. C. Williams The compounds we have tested are listed in table 1 together with their laboratory numbers which will be used throughout the ensuing text. The compounds have been divided into groups, and this order and grouping is maintained in the re maining tables in the paper to simplify cross-reference.
Those compounds whose method of preparation is not given by reference in the table were prepared by the methods described. 
Depression of righting reflex rats
When rats that are tied supinely on a table are released, they immediately right themselves. If, however, the supine rats are injected intraperitoneally with mor phine, they take an appreciable time (3-20 sec.) to get to their feet when released \ hr. after the injection. This fact is the basis of a test for morphine activity devised by Eddy & Howes (1935a) .
Method
Eddy & Howes record the least dose of a substance which will prevent the im mediate righting of 75 % of a group of twenty adult male rats. In our preliminary tests we first injected one or two rats intraperitoneally with different doses of the substance to be tested to assess its toxicity and general effects. We then tied out eight male rats, weighing 90-110 g., on an operating table, and injected them intra peritoneally with a dose as high as the toxicity of the substance allows. Any delay in the righting of the rats | hr. later was noted as well as any general effects to be seen when the rats had got to their feet. In one instance (M2) the amount of material available was insufficient for tests to be done on groups of eight rats, while larger groups were used for some of the more active compounds. All the substances were injected as aqueous solutions of their hydrochlorides and the doses are in terms of hydrochloride. 
Results
The results of these tests are given in table 2. All the compounds when injected in fatal or nearly fatal doses produced convulsions or muscular incoordination, and violent waving of the tail was a commonly observed symptom (particularly with M3, M2, Ml, M4 and M 12) . This waving of the tail resembles the Straub sign produced in mice by the injection of morphine and many other pharmacologically active drugs (cf. Heinekamp 1922) . The incoordination produced by the synthetic compounds has some bearing on the depression of the righting reflex. The delay in righting may be due not so much to a depression of the reflex mechanism as to a simple inability to get upright owing to this muscular incoordination. Certainly at least half of the rats with delayed righting exhibited incoordination when they did finally get to their feet. Whilst this objection to the interpretation of the results must be borne in mind, we do not believe that it completely obliterates the value of the test. There were many cases in which rats which took some considerable time to right themselves exhibited no apparent incoordination and their behaviour appeared to be indistinguishable from that of rats injected with morphine. In rats receiving fatal doses death was often preceded by a phase of complete prostration. Frothing at the mouth was produced by injections of Ml, M4 and M14. The results in table 2 show that the capacity for depressing the righting reflex was much lower in the synthetic compounds than in morphine. It is also evident that our rats are more resistant to the depressing action of morphine than are those of Eddy & Howes (1935a) who reported a 76 % depression with a dose of 6*8 mg. of morphine per kg. There does not appear to be any coherent relation between chemical structure and pharmacological activity. Points that may be noted are that the di-amino compound M 2 has no demonstrable depressing activity; that the ^-hydroxy compound M4 and the compounds with hydroxy or methoxy groups attached to one or both phenyl rings (M15, M14, and Ml) are less active than the parent compound M3, and that the cyclo-hexyl compounds (M16-M18) are more active, though more toxic, than M3. The /?-keto compound possesses no depressing action in the doses it was possible to test. Methylation of the aminogroup increased the depressing activity (compare the following pairs of com pounds: M5 and M8, M6 and M9, and M 12 and M7). The addition of methyl or ethyl groups in the /^-position increased the toxicity of M 4 and had no demonstrable action on the depressing activity.
Eddy (1935) finds that codeine (methyl morphine) has less depressing activity than morphine. The only comparable pair of compounds in our series is M15 and M 14, in which methylation of the phenolic hydroxy group actually increases the depressing action. Eddy & Howes (19356) also find that removal of the alcoholic hydroxy group in members of the morphine series, and its substitution by hydrogen enhances depressant action and toxicity. This is similar to our finding that M3 is more active than M4, although it is not so toxic.
Elevation of the blood-sugar level in rabbits
The increase in the blood sugar produced by morphine in dogs (Ross 1918) and other animals has been investigated fairly extensively. The increase is large and may be inhibited by the injection of insulin (Stewart & Rogoff 1923) . Interference with the liberation of adrenaline or removal of the adrenal glands reduces the hyperglycaemia produced by morphine but does not abolish it (Stewart & Rogoff 1922; Houssay, Lewis, Molinelli & Marenzi 1928) .
Method
Adult rabbits were starved for 18 hr. and then injected subcutaneously with an aqueous solution of the hydrochloride of the substance to be tested. Samples of blood were taken before, and at hourly intervals for 3 hr. after, the injection. The maximum rise in blood sugar (which was attained at the 2nd or 3rd hour in all cases) was expressed as percentage increase over the initial value. Increases of less than 20 % are not considered to be significant. When a rabbit was used more than once, at least 7 days were allowed to elapse between successive tests.
Results
The results obtained are tabulated in table 3. The number of animals used has unfortunately been small so that only rough quantitative comparisons can be made. Diphenylethylamine has quite marked capacity for raising the blood sugar. Addi tion of an amino group in the /^-position (M2) decreases this activity. Addition of a single hydroxy group to the a-phenyl ring (M15) also decreases the activity; methylation of this phenolic hydroxy group (M14) markedly increases the activity. Addition of an alcoholic hydroxy group in the /^-position (M4) abolishes the capacity to raise the blood sugar though some activity is restored if methyl or T able 3. R ise in blood sugar produced b y subcutaneous in jectio n IN RABBITS. N um ber of animals in brackets mean max. increase in blood sugar symptoms produced substance ethyl groups are also added in the //-position (M5 and M6). Methylation of the amino group still further enhances the activity of these two compounds (M 8 and M9) though it does not have such an effect in the /?-keto compound (M12 and M7). The cyclo-hexyl compounds (M16-18) appear to be among the most active in the list. The presence of one or two methoxy-groups appears to favour the develop ment of blood-sugar raising activity (M14, M l and M17). We have not been able to find any references in the literature to the comparative activity of morphine derivatives in this respect. It may be noted that convulsions developed in a number of the animals injected with the higher doses of some of the substances. No consistent relation was found between the production of convulsions and elevation of the blood sugar. When two rabbits were injected with 0-75 unit of insulin and 75 mg./kg. of the hydrochloride of M3 at the same time, the mean blood-sugar level was 87 mg. per 100 ml. before the injections and was 81, 74, and 98 mg. per 100 ml. at hourly intervals afterwards. This indicates that insulin antagonises the blood-sugar raising activity of M3 as it does that of morphine (Stewart & Rogoff 1923) .
---------------------------------------------------------------A -------------------------

Method General effects produced in cats
Cats were injected intramuscularly with aqueous solutions of the hydrochlorides of morphine and the synthetic substances. Owing to the difficulty in obtaining cats for experimental work the tests have been carried out on one or two cats only.
Many of the animals were used more than once; in these cases at least 7 days have elapsed between successive tests. We concentrated on noting the production of pupil dilatation, vomiting and hyperexcitability. In assessing pupil dilatation and hyperexcitability the responses have been arbitrarily classified as + , + -f, or + + + in degree, and only the + + or + + + responses are counted as positive in table 3. Many of the cats which did not vomit exhibited obvious signs of nausea, but classification of the degree of nausea proved very difficult so that little quantitative reliance could be placed on the results. We found considerable in dividual variations in response to morphine and to the synthetic compounds.
Results
The figures given in table 3 summarize the results of these experiments. The smallness of the number of cats used does not allow very definite conclusions to be drawn. The different activities possessed by morphine are present in different degrees in the synthetic compounds. Diphenylethylamine (M3) and its //-hydroxy derivative M4 both dilate the pupils and produce hyperexcitability; addition of E. C. Dodds, W. Lawson and P. C. Williams 
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methyl or ethyl groups also in the //-position (M5 and M6) appears to increase the activity which is still further increased by methylation of the amino nitrogen (M 8 and M9). It should be noted that those cats which had convulsions are placed in the hyperexcitable category even if no very definite signs of this were present before the convulsions occurred; it seems reasonable, however, to regard con vulsions in these cats as an expression of pronounced hyperexcitability.
Only three of our compounds produced vomiting (M7, M16 and M18), while two others (Ml4 and M17) caused definite symptoms of nausea such as con tinuous licking of the lips. We have found the greatest individual variations in the response of different cats to morphine when assessing its emetic action.
Profuse salivation was produced in three of fifteen cats injected with 0*2-20 mg. of morphine hydrochloride per kg. This symptom was also noted in one or more of the cats injected with the synthetic compounds. Exceptions in which salivation was not noted were the cats injected with M l, M3, M12, M15, M17 and M18.
Effect on blood pressure in cats. Cats anaesthetized with sodium amytal were injected intravenously with 1, 2 or 5 mg. of the hydrochloride of each compound per kg. Under these circumstances morphine produces a purely pressor response in the 1 mg. dose and an initial depressor and secondary pressor response with the higher doses. The synthetic compounds produced a slight depressor response or no response at all when given in doses of 1 or 2 mg./kg. The higher doses produced a more marked depression which was serious in some cases (particularly with M5, M6, M16, M17 and M18). M4 which was the most active compound in the clinical trials produced only very slight and short-lived depression of the blood pressure even in doses of 5 mg./kg.
C l i n i c a l i n v e s t i g a t i o n s
As there is no precise biological test for the action of morphine, convincing proof of the analogous action of our compounds can only come from the clinical demonstration of analgesic action. For this purpose five of the compounds were administered orally to patients suffering from painful pressure effects of secondary deposits in malignant disease. In each case the patients had been under varying doses of morphine at 4-hourly intervals. The tests were conducted by substituting at 4-hourly intervals doses of the compound under test without informing the patient. If the patient complained of very severe pain, then morphine treatment was reinstituted, but if there appeared to be a certain amount of relief, the dose of the compound was increased to the limit permitted by its toxicity as shown in animal tests. By this method it is possible to get a qualitative opinion as to whether the compounds possessed any analgesic properties at all. In view of the extreme variability of the conditions, no attempt whatsoever is made to assess the potency of the substances in terms of morphine. Table 5 shows those with definite activity and gives the rough order of their potency. Substances M3 and M4 proved to have definite analgesic properties, while M2, M7 and M18 were inactive. M3 when given in doses of 200 mg. every 3 hr. relieved the patients' pain, but mental confusion developed after about 1 hr. In normal individuals M 3 in similar doses produced elation and slight muscular incoordination like that produced by small doses of alcohol. Most patients refused to take further M3 after receiving a series of doses. The results with M4 were more successful. It was tried on 14 patients and gave complete relief of pain in all cases without any signs of mental confusion or undesirable after-effects. No clinical details are given in table 5 which only briefly indicates the analgesic therapy being given when the tests were instituted. A typical example of M4 treatment follows: E.B., a male aged 49, was suffering from Hodgkin's disease with deposits in the spine and mediastinum. Before the test the patient had severe pain in the spine which was controlled by two Weganin' tablets 4-hourly during the day, and aspirin gr. 10 plus nepenthe 15 minims twice during the night. On 23 April 1943 this treatment was stopped, and at 2 p.m. 200 mg. of M4 were given in a capsule; the pain was relieved, but not completely. At 6 p.m. a further 200 mg. were given and there was complete relief until 6.30 p.m. At 10 p.m. and 4-hourly afterwards 200 mg. of M 4 were given with complete relief from pain. It would appear that this substance is worth a detailed clinical trial. All patients receiving morphine compounds prior to experim ents.
Methods of sy nth esis
4:-A'-Dimethoxy-ocj3-diphenylethylamine (Ml). Deoxyanisoin oxime (14 g.) dis solved in alcohol (150 c.c.) was reduced at 50° by gradual addition of 2\ % sodium amalgam (250 g.), acidity being maintained by addition of glacial acetic acid. After dilution with water the solution was decanted from mercury and a small amount of oily unchanged oxime removed by filtration. The amine was precipitated from this solution by addition of ammonia. It was crystallized from dilute alcohol or benzene-light petroleum; colourless prisms, m.p. 103-104°.
(Found: C, 74-7; H, 7-45. C16H190 2N requires C, 74*7; H, 7*4 %.) The hydrochloride crystallized from alcohol in needles, m.p. 210-212°. fi-Hydroxy-afi-diphenyl-n-butylamine(M6) was prepared by the addition of desylamine hydrochloride to a large excess (6 mol.) of a Grignard solution from magnesium and ethyl iodide. After 1 hr. the solution was heated on a water bath for 30 min. and decomposed with ice and ammonium chloride. The free base was a viscous liquid which could not be crystallized. The hydrochloride, prepared by passing HC1 gas into the dry ethereal solution of the base, crystallized from alcohol in needles, m.p. 215-217°.
(Found: C, 69*0; H, 7-3 ; Cl, 12-3. C16H19ON, HC1 requires C, 69-2; H, 7-3; Cl, 12-7 %.) fl-Hydroxy-afi-diphenyl-n-propyl dimethylami (M8). phenyl ketone hydrochloride (Rabe 1912) was added gradually to a Grignard solu tion from methyl iodide and magnesium (6 mol.). After boiling for 1 hr. the mixture was decomposed by ice and ammonium chloride. The product, an oil which did not crystallize, was dissolved in dilute hydrochloric acid from which the hydrochloride of the base crystallized in irregular hexagonal plates, m.p. 248-250°.
(Found: C, 69-9; H, 7-7; Cl, 12-0. C17H21ON, HC1 requires C, 70-0; H, 7-6; Cl, 12-15 %.)
P-Hydroxy-uft-diphenyl-ia-butyl dimethylamine (M9), prepared in a similar manner, was also an oil which gave a hydrochloride crystallized from water as a micro crystalline powder, m.p. 251-252°.
(Found: C, 70-1; H, 7-6; Cl, 11-6. C18H230N,HC1 requires C, 70-7; H, 7-9; Cl, 11-6 %.)
cc-(p-Anisyl)-fi-phenylethylamine (M14), prepared by reduction of 4-methoxy deoxybenzoin with sodium amalgam and acetic acid in alcohol at 50°, was an oil which was converted to its hydrochloride by dissolving in dilute hydrochloric acid. The product, recrystallized from water in colourless needles had m.p. 215-217°.
(Found: C, 68-1; H, 6-9; Cl, 13-0. C15H17ON, HC1 requires C, 68-3; H, 6-9; Cl, 13-4 %.)
a,-(p-Hydroxyphenyl)-fi-phenyl ethylamine (M15). Phenyl anisyl ethylamine hydrochloride (5 g.) was boiled during 20 min. with hydriodic acid (12 c.c. colour less, sp. gr. 1-7). After cooling, the solution was diluted, filtered and made alkaline with ammonia. The gummy precipitate quickly solidified and was converted to the hydrochloride which after crystallization from a small volume of water melted at [194] [195] H, Cl, HC1 requires C, H, Cl, (o-cyclo-Hexyl acetophenone, cyclo-Hexyl acetyl chloride was dissolved in excess dry benzene and powdered anhydrous aluminium chloride gradually added, cooling in water. After 1 hr., the mixture was decomposed with ice water, the benzene solution washed with dilute NaOH solution, dried and distilled. The ketone was a colourless oil distilling at 169-170°/12 mm.
(Found: C, 82-7; H, 9-1. C14H180 requires C, 83-1; H, 9-0 %.) It forms a 2 : 4^-dinitrophenyl hydrazone which crystallizes from xylene in r of orange prisms, m.p. 157-158°, and an oxime, crystallized from dilute alcohol in flat needles, m.p. 100-101°. tx-Phenyl-fi-cyclo-hexyl ethylamine (M16). The above oxime was reduced by sodium amalgam and acetic acid in alcohol solution at 50°. After dilution the solution was decanted from mercury, allowed to stand overnight, filtered, and made alkaline with ammonia. The amine was extracted with ether, dried and distilled, b.p. 162-164°/12 mm.
(Found: N, 7-1. C14H21N requires N, 6-9 %.)
The picrate, yellow micro-prisms from benzene-ethyl acetate, melts at 183-18 The hydrochloride crystallized from water in colourless needles, m.p. 280-282°. Treatment with benzoyl chloride in 10 % aqueous NaOH gave a benzoyl deriv ative which crystallized from alcohol in prismatic rods, m.p. 168°.
( The experiments reported above show that each of the activities of morphine which we have investigated is possessed by some of our eighteen compounds; all the compounds have at least one of these properties of morphine, while some of them possess most of them. It is unlikely that a series of compounds able to depress the righting reflex in rats, raise the blood-sugar level in rabbits, dilate the pupil and cause hyperexcitability, convulsions, and vomiting in cats has not the same mode of action as morphine itself. The fact that alterations in chemical structure do not produce parallel alterations among the biological actions is not unexpected; similar erratic alterations in biological action are shown when slight modifications are made in the morphine molecule. No coherent relation between chemical structure and pharmacological properties is apparent in the compounds we have described any more than in the morphine, carcinogen, oestrogen, or other similar series. Analgesic potency is unfortunately not related to any of the other tested activities of the synthetic substances (see table 6 ). We have not been able to find any reference in the literature to the properties of the compounds we have described, though /?-hydroxy-a: /?-diphenylethylamine (M4) has been examined owing to its resemblance to ephedrine (Tiffeneau, Levy & Boyer 1928; Tainter 1933) . It was reported to have slight depressor action in anaesthetized cats. There have been many previous attempts to produce a simple synthetic substance having the analgesic properties of morphine without its undesirable side actions and liability to produce addiction. One of the most extensive investigations has been that conducted under the auspices of the Committee on Drug Addiction of the United States National Research Council. Their Report and Collected Reprints published in 1941 contain the results of investigations of the pharmacological and clinical actions of a large series of morphine derivatives and of synthetic phenanthrene and carbazole compounds structurally related to morphine (see also Small, Eddy, Mosettig & Himmelsbach, 1938) . Though interesting resemblances to the properties of morphine are possessed by some of their synthetic compounds, none of them is sufficiently active to be of clinical value. A more practical compound is that discovered in Germany and there given the name 'Dolantin' ('Demerol' in the U.S.A. and 'Pethidine' in this country). This substance is the carboxylic acid ethyl ester of l-methyl-4-phenyl piperidine, which may be regarded as a simple morphine analogue since morphine itself contains the 4-phenyl piperidine nucleus. It has been shown to have many of the pharmacological properties of morphine, but unfortunately does not appear to have been tested by any of the methods we have used. An extensive clinical investigation of its analgesic properties has been reported by Batterman (1943) in a paper which also reviews the earlier pharmacological work on the compound. Well over a thousand patients with varying degrees of pain were treated with ' Demerol ' which proved to be effective for about 3 hr. when given intramuscularly in doses of 50-200 mg. Oral ad ministration is reported to be less effective. In so far as our short series of clinical trials allows of a comparison, ' Demerol ' does not appear to be more effective than M4. Another interesting observation in this connexion is that of Lettre & Albrecht (1942) who have shown that a-phenyl-/?-(p-anisyl) ethylamine pos sesses about 10 % of the activity of colchicine on mitosis. Colchicine is another pharmacologically active compound containing the phenanthrene nucleus. a-Phenyl-/?-(p-anisyl) ethylamine differs from M14 only in the position of the methoxy group.
The facts reported in this paper and those discussed in the last paragraph demon strate that the principle that simple synthetic analogues may be prepared with all the biological properties of complex naturally-occurring compounds (first proved by the synthesis of stilboestrol and hexoestrol) is capable of extension to other series of compounds.
C o n c l u s i o n s Diphenylethylamine and seventeen related compounds have been synthesized and tested for morphine-like activity.
The following properties of morphine are possessed in differing degrees by some or all of the compounds: capacity to depress the righting reflex in rats, to raise the blood-sugar level in rabbits, and to cause hyperexcitability, pupil dilatation, and vomiting in cats.
